archive-com.com » COM » N » NEXTECHINVEST.COM

Total: 35

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Team | T Lips | Nextechinvest
    of Goldman Sachs Bank AG and American International Group AIG Private Bank Ltd in Switzerland Lips holds a PhD in economics from the University of Zurich Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26 8006 Zurich Switzerland P 41 0 44 366 66 11 F 41 0 44 366 66 10 Newsletter Registration Please

    Original URL path: http://www.nextechinvest.com/en/team/t-lips.html (2016-04-26)
    Open archived version from archive


  • Team | S Demaré | Nextechinvest
    several large institutional investors For 20 years before joining Ortec she held leading positions in corporate finance business and pensions fund management at Dow Chemical Mrs Demaré obtained her Master of Science in Economics from the Business School of Helsinki and is a Chartered Financial Analyst Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26

    Original URL path: http://www.nextechinvest.com/en/team/s-demar%C3%A9.html (2016-04-26)
    Open archived version from archive

  • Team | M Shargorodska | Nextechinvest
    and prior to her business career worked for three years as an oncological nurse in Boston USA Marina combines substantial expert knowledge in the healthcare biotechnology and financial industries and is an Advisory Board Member at London based think tank Official Monetary and Financial Institutions Forum OMFIF focused on all activities formed around a core of public sector asset and reserve holders Sitemap Sitemap Home About Nextech Invest Oncology Expertise

    Original URL path: http://www.nextechinvest.com/en/team/m-shargorodska.html (2016-04-26)
    Open archived version from archive

  • Team | R Bertoni | Nextechinvest
    entrepreneur establishing an Art Gallery in Zurich Rita Bertoni graduated from the Commercial School St Gallen and holds a certificate in office management Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26 8006 Zurich Switzerland P 41 0 44 366 66 11 F 41 0 44 366 66 10 Newsletter Registration Please fill in the

    Original URL path: http://www.nextechinvest.com/en/team/r-bertoni.html (2016-04-26)
    Open archived version from archive

  • Team | R Staehli | Nextechinvest
    and as a Financial Accountant for several Swiss SMEs Stähli is a Swiss certified expert for controlling and accounting and holds a MSc from the Federal Institute of Technology ETH Sitemap Sitemap Home About Nextech Invest Oncology Expertise Investment Strategy Selection Process Investment Criteria Team Portfolio Investors News Contact Nextech Invest Ltd Turnerstrasse 26 8006 Zurich Switzerland P 41 0 44 366 66 11 F 41 0 44 366 66

    Original URL path: http://www.nextechinvest.com/en/team/r-staehli.html (2016-04-26)
    Open archived version from archive

  • News | 2016 | Nextechinvest
    Meeting 2016 17 03 2016 Kura Oncology reports fourth quarter and full year 2015 operational and financial results 15 03 2016 Blueprint Medicines announces a USD 1B collaboration with Roche to accelerate and expand its development of novel medicines in the field of cancer immunotherapy 11 03 2016 Blueprint Medicines reports fourth quarter and full year 2015 financial results 11 03 2016 Kura Oncology to report fourth quarter and full year 2015 financial results 04 02 2016 Blueprint Medicines appoints Lonnel Coats to Board of Directors 27 01 2016 Tracon Pharmaceuticals announces initiation of TRC102 Phase 2 clinical trial in Glioblastoma 25 01 2016 Tracon Pharmaceuticals announces FDA Orphan Drug Designation for TRC105 in Soft Tissue Sarcoma 21 01 2016 Jounce Therapeutics appoints Perry Karsen to its Board of Directors 11 01 2016 ImaginAb appoints Benjamin Chen Ph D as CEO Joseph Limber as Chairman and forms Medical Advisory Board 06 01 2016 TetraLogic Pharmaceuticals announces data on lead clinical programs 05 01 2016 Blueprint Medicines strengthens executive leadership team 04 01 2016 Sunesis Pharmaceuticals announces European Medicines Agency validates marketing authorization application for Vosaroxin in AML Events 03 06 07 06 2016 ASCO Annual Meeting Chicago USA Past Events 16 04 20 04 2016 AACR Annual Meeting New Orleans USA 04 04 05 04 2016 Cancer Advance Boston Boston USA 21 03 23 03 2016 Immunotherapy of Cancer Conference Munich Germany 15 03 16 03 2016 Annual European Life Science CEO Forum Zürich Switzerland 16 02 17 02 2016 Family Office Forum Dubai UAE 11 01 15 01 2016 J P Morgan 34th Annual Healthcare Conference San Francisco USA Newsletter Keep me updated about investment opportunities in the area of oncology and life sciences Register Latest Newsletters February 2016 November 2015 September 2015 Sitemap Sitemap Home About Nextech Invest

    Original URL path: http://www.nextechinvest.com/en/news/2016.html (2016-04-26)
    Open archived version from archive

  • News | 2015 | Nextechinvest
    from ongoing Phase I study of enoblituzumab 06 11 2015 Tracon Pharmaceuticals presents updated Phase Ib results for TRC105 in combination with Inlyta 05 11 2015 Tracon Pharmaceuticals presents interim results from TRC105 trial in Sarcoma 04 11 2015 Kura Oncology announces pricing of public offering of common stock 03 11 2015 ImaginAb presents precision immuno imaging data at SITC 2015 03 11 2015 Jounce Therapeutics appoints Elizabeth Trehu M D as CMO 02 11 2015 TetraLogic Pharmaceuticals announces the opening of an IND for SHAPE gel in alopecia areata 28 10 2015 Kura Oncology announces launch of public offering of common stock 22 10 2015 MacroGenics and Merck to collaborate on immuno oncology study 14 10 2015 Kura Oncology appoints Thomas Malley to board of directors 13 10 2015 ImaginAb and Lilly announce preclinical immuno oncology collaboration 12 10 2015 Tracon Pharmaceuticals announces initiation of TRC102 combination Phase Ib II trial Events Past Events 05 12 08 12 2015 ASH Annual Meeting Orlando USA 04 11 08 11 2015 SITC Annual Meeting Maryland USA 03 11 04 11 2015 Family Office Forum Zurich Switzerland 02 11 04 11 2015 BIO Europe Munich Germany 29 09 30 09 2015 Biotech in Europe Forum Basel Switzerland 15 09 16 09 2015 Family Office Forum London UK 29 05 02 06 2015 ASCO Annual Meeting Chicago USA 27 04 29 04 2015 Family Office Forum Wiesbaden Germany 18 04 22 04 2015 AACR Annual Meeting Philadelphia USA 17 03 18 03 2015 The 26 Annual Cancer Progress Conference New York USA 03 03 04 03 2015 8th Annual European Life Sciences CEO Forum Zurich Switzerland 23 02 2015 Sachs Cancer Bio Partnering Investment Forum New York USA 12 01 16 01 2015 JP Morgan 33rd Annual Healthcare Conference San Francisco USA Newsletter

    Original URL path: http://www.nextechinvest.com/en/news/2015.html (2016-04-26)
    Open archived version from archive

  • News | 2014 | Nextechinvest
    announces first closing of oncology fund IV 06 10 2014 Sunesis announces results from pivotal phase 3 VALOR trial of vosaroxin 29 09 2014 MacroGenics and Takeda enter second strategic alliance to develop multiple additional DART therapeutics 24 09 2014 Tracon Pharmaceuticals announces results from clinical trials of TRC105 in patients with ovarian cancer to be presented at the 2014 Annual Meeting of the European Society for Medical Oncology 22 09 2014 Tracon Pharmaceuticals completes 27 million financing and expands management team and board of directors 19 09 2014 Blueprint Medicines reports first discovery of actionable genetic alterations in a deadly cancer 10 09 2014 Blueprint Medicines discovers novel cancer drug targets 08 09 2014 Blueprint Medicines presents positive data on BLU 554 for hepatocellular carcinoma 04 09 2014 Tracon Pharmaceuticals initiates Phase 2 clinical trial of TRC105 in patients with soft tissue sarcoma 24 07 2014 Blueprint Medicines appoints Jeffrey Albers as Chief Executive Officer 28 06 2014 Interview with Professor Glenn Dranoff 17 06 2014 TetraLogic Pharmaceuticals announces pricing of 47 million offering of convertible notes 09 06 2014 TetraLogic Pharmaceuticals announces data indicating birinapant s breadth of activity in models of infectious disease Events Past Events 26 11 2014 Zürcher StiftungsDialoge Zurich Switzerland 11 11 12 11 2014 Family Office Forum Zurich Switzerland 04 11 2014 Trendforum Vermögens Management Frankfurt Germany 30 09 01 10 2014 Sachs Biotech in Europe Forum Basel Switzerland 23 06 26 06 2014 BIO International Convention San Diego USA 12 06 2014 Annual Partners Meeting 2014 Widder Hotel Zurich 03 06 04 06 2014 Limited Partners Summit London UK 05 05 07 05 2014 Family Office Forum Wiesbaden Germany 05 04 09 04 2014 AACR Annual Meeting 2014 San Diego USA 13 01 16 01 2014 JP Morgan 32nd Annual Healthcare Conference

    Original URL path: http://www.nextechinvest.com/en/news/2014.html (2016-04-26)
    Open archived version from archive



  •